Vivanza Biosciences Limited (BOM:530057)
India · Delayed Price · Currency is INR 1.700
+0.030 (1.80%)
At close: Oct 16, 2026
Vivanza Biosciences Market Cap
Vivanza Biosciences has a market cap or net worth of 68 million as of October 16, 2026. It is the 49,952nd most valuable company in the world and the 5,376th biggest in India. Its market cap has decreased by 15.00% in one year.
Market Cap
68.00M
Enterprise Value
169.27M
Revenue
1.17B
Global Rank
Country Rank
#5,376 India
PE Ratio
14.13
ChartMarket Cap Chart
Since October 23, 2012, Vivanza Biosciences's market cap has decreased from 178.64M to 68.00M, a decrease of -61.93%. That is a compound annual growth rate of -6.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 68.00M | -22.73% |
| Dec 31, 2025 | 88.00M | -35.67% |
| Dec 31, 2024 | 136.80M | -68.25% |
| Dec 29, 2023 | 430.80M | -30.96% |
| Dec 23, 2022 | 624.00M | -12.92% |
| Dec 27, 2021 | 716.60M | 59.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Desh Rakshak Aushdhalaya | 153.28M |
| Shamrock Industrial Company | 147.84M |
| Unjha Formulations | 141.14M |
| Beryl Drugs | 120.76M |
| Ortin Global | 113.84M |
| Emmessar Biotech & Nutrition | 109.01M |
| Brawn Biotech | 76.21M |
| Ganga Pharmaceuticals | 73.89M |